Global Health Alert: Emerging Threats and Breakthroughs in the Medical World
Global health updates reveal rising Hantavirus cases linked to a cruise, new Ebola travel bans, Eli Lilly's vaccine acquisitions, and stolen glucose sensors. Agilent raises its profit forecast amid strong demand, while Biogen faces an antitrust probe. These developments spotlight urgent health challenges and industry advancements worldwide.
The World Health Organization has reported a rise in Hantavirus cases linked to a cruise outbreak, as new cases are identified in Spain. This brings the total to 13, with affected passengers in quarantine, WHO chief Tedros Adhanom Ghebreyesus noted.
In a bid to curb the Ebola spread, Canada and the Bahamas have imposed travel bans on residents from the Democratic Republic of the Congo, Uganda, and South Sudan. The temporary measure is aimed at keeping Ebola contained and preventing its spread within Canada, according to the government.
Eli Lilly has announced plans to acquire three vaccine developers in deals valued at $3.8 billion. This strategic move indicates Lilly's strengthened focus on infectious disease prevention, acquiring Curevo, LimmaTech Biologics, and the Vaccine Company.
(With inputs from agencies.)
Google News